Arrowhead Pharmaceuticals Inc (MEX:ARWR)
MXN 454.55 (0%) Market Cap: 198.50 Bil Enterprise Value: 184.32 Bil PE Ratio: 0 PB Ratio: 18.42 GF Score: 49/100

Arrowhead Pharmaceuticals Inc at RBC Capital Markets Global Healthcare Conference Transcript

May 20, 2026 / 01:00PM GMT
Release Date Price: MXN454.55
Luca Issi
RBC Capital Market - Analyst

Luchaisi, Senior Biotech Analyst here at RBC Capital Market. And today is our great privilege to have Arrowhead as part of our 2026 Global Healthcare Conference. To represent the company, we have James Hamilton, Chief Michael Oster, as well as Vince Anzaloni, Head of IR. James and Vince, thanks so much for being here. How are you guys doing today?

Vince Anzalone
Arrowhead Pharmaceuticals, Inc - Vice President, Finance & Investor Relations

Great. Thanks for inviting us. Pleasure to be here.

Luca Issi
RBC Capital Market - Analyst

Great.

We have a long list of questions here, but maybe before we go into specific, maybe I'll ask to you, Vince, just big picture. I know you guys have been on the road a lot and had great engagement with investors and whatnot. What has been the feedback? What progress has the organization made over the last few months? And most importantly, what's ahead here for Arrowhead?

Unidentified_3

Is that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot